A breakthrough in understanding the regulation of MHC-I genes and their defective expression in cancers came from the work of Kobayashi group on the nucleotide-binding leucine-rich repeat-containing receptor (NLR) family protein NLRC5 [130]. The gene discussed is NLRC5; the disease is cancer.